Production (Stage)
scPharmaceuticals Inc.
SCPH
$3.64
$0.092.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -90.78M | -85.15M | -80.12M | -60.64M | -57.71M |
| Total Depreciation and Amortization | 160.00K | 148.00K | 227.00K | 515.00K | 572.00K |
| Total Amortization of Deferred Charges | 4.49M | 4.49M | 4.49M | -- | -- |
| Total Other Non-Cash Items | 26.99M | 23.07M | 18.66M | 2.32M | 149.00K |
| Change in Net Operating Assets | -10.84M | -13.09M | -13.77M | -8.72M | -3.46M |
| Cash from Operations | -69.98M | -70.54M | -70.51M | -66.54M | -60.45M |
| Capital Expenditure | -21.00K | -21.00K | -46.00K | -37.00K | -40.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.00K | 29.32M | 55.82M | 32.90M | 42.32M |
| Cash from Investing | -20.00K | 29.30M | 55.77M | 32.86M | 42.28M |
| Total Debt Issued | 46.77M | 46.77M | 46.77M | -- | -- |
| Total Debt Repaid | -50.00M | -50.00M | -50.00M | -- | -- |
| Issuance of Common Stock | 54.05M | 54.23M | 54.53M | 999.00K | 1.33M |
| Repurchase of Common Stock | 0.00 | -166.00K | -166.00K | -166.00K | -166.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 18.27M | 19.25M | 20.05M | -- | -- |
| Cash from Financing | 69.09M | 70.08M | 71.18M | 833.00K | 1.16M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -903.00K | 28.84M | 56.44M | -32.85M | -17.01M |